Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Neuropharmacology. 2019 Apr 6;158:107596. doi: 10.1016/j.neuropharm.2019.04.002

Table 2.

Intermediate precision and accuracy, matrix effects and recovery.

Analyte Nominal
Conc.
Intermediate
precision and
accuracy
Matrix Effects (ME) Recovery
(pg/mL) CV
(%)
Bias
(%)
ME
(%)
CV
(%)
ME corr (%) a % CV
(%)
Carfentanil 15 9.5 −7.5
25 7.9 −7.6 97 13 107 91 11
501 7.6 −3.1
4008 6.6 3.2 103 2.3 101 88 12
Norcarfentanil 15 15 4.4
25 8.3 3.8 89 5.8 91 84 10
501 9.1 −2.4
4008 6.4 −0.6 98 2.8 97 81 5.1
a

ME corrected with Internal Standard